Akeso has launched a Phase II clinical study in the United States evaluating a cadonilimab-based combination regimen for...
Innovent Biologics and Spero Therapeutics have entered into an exclusive licence agreement for IBI355, also known as SP0...
HUYABIO International has reported statistically significant and clinically meaningful topline Phase 3 results for HBI-8...
Insmed has reported positive 12-month data from the ongoing open-label extension study of treprostinil palmitil inhalati...
Frederick Appelbaum, MD, executive vice president and professor in the clinical research division at Fred Hutch Cancer C...
Orasis Pharmaceuticals and Aspen Australia have announced submission of a New Drug Application in Australia for BESKA, p...
Maxona Pharmaceuticals has received U.S. FDA clearance of its Investigational New Drug application for a Phase 2 clinica...
Lakewood-Amedex Biotherapeutics has announced preclinical safety data supporting clinical dose selection for its upcomin...
Versiti, Inc., a nonprofit organization dedicated to improving blood health for patients everywhere, has joined the Bloo...
MEDIPOST has treated the first U.S. participant in its Phase III clinical trial evaluating an investigational mesenchyma...
Novo Nordisk has reported interim Phase III FRONTIER4 extension data for denecimig, also known as Mim8, in people with h...
BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim have announced the launch of a new research t...
Agilent Technologies Inc. has announced the latest expansion of its Altura HPLC column portfolio with the introduction o...
RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and comme...
FibroBiologics has completed manufacturing of the third batch of CYWC628 drug product for its ongoing Phase 1/2 clinical...
Matica Biotechnology has entered a partnership with VaxDome to support development of antigen-agnostic antiviral-vaccine...
Brii Biosciences has reported topline end-of-treatment data from its ongoing Phase 2b ENRICH and ENHANCE studies evaluat...
Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
Viking Therapeutics has initiated a Phase 1 clinical study of VK3019, an investigational dual amylin and calcitonin rece...
UniXell Biotechnology has received U.S. FDA Investigational New Drug clearance for UX-DA003, its allogeneic induced plur...
Agilent Technologies Inc. has announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software modu...
US-based Waters Corporation and IMU Biosciences, a UK-based biotechnology startup, have announced a strategic partnershi...
